tiprankstipranks
Advertisement
Advertisement

ADAG Stock Latest News

Adagene Extends Cash Runway and Advances Muzastotug Through Mid-2026 Clinical Milestones
Company AnnouncementsAdagene Extends Cash Runway and Advances Muzastotug Through Mid-2026 Clinical Milestones
13d ago
6K
ADAG
Adagene Discloses Preliminary US$127.9 Million Cash Balance as of June 30, 2026
PremiumCompany Announcements
Adagene Discloses Preliminary US$127.9 Million Cash Balance as of June 30, 2026
2M ago
6K
ADAG
Analyst Initiates Buy on Muza Developer, Citing Promising MSS CRC Data, Clear Registrational Path, and Broader Expansion Upside Despite Cash Constraints
PremiumRatings
Analyst Initiates Buy on Muza Developer, Citing Promising MSS CRC Data, Clear Registrational Path, and Broader Expansion Upside Despite Cash Constraints
4M ago
ADAG
Adagene Showcases Promising Muzastotug Triplet Data at AACR 2026 for Liver and Colorectal Cancers
PremiumCompany Announcements
Adagene Showcases Promising Muzastotug Triplet Data at AACR 2026 for Liver and Colorectal Cancers
4M ago
6K
ADAG
Adagene presents data from two Phase 1b/2 studies of muzastotug at AACR
PremiumThe Fly
Adagene presents data from two Phase 1b/2 studies of muzastotug at AACR
4M ago
ADAG
Adagene: Deepening Dose‑Response Evidence and Strategic Partnership Support Buy Rating on Lead CTLA‑4 Program
PremiumRatingsAdagene: Deepening Dose‑Response Evidence and Strategic Partnership Support Buy Rating on Lead CTLA‑4 Program
5M ago
ADAG
Adagene price target raised to $10 from $9 at Guggenheim
Premium
The Fly
Adagene price target raised to $10 from $9 at Guggenheim
5M ago
ADAG
Adagene 18.666M share Spot Secondary priced at $3.75
Premium
The Fly
Adagene 18.666M share Spot Secondary priced at $3.75
5M ago
ADAG
Adagene enters pact with Incyte for combination of muzastotug, INCA33890
PremiumThe Fly
Adagene enters pact with Incyte for combination of muzastotug, INCA33890
5M ago
ADAG
Adagene announces results from the latest data cut of muzastotug study
PremiumThe Fly
Adagene announces results from the latest data cut of muzastotug study
5M ago
MRK
ADAG
Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer
PremiumCompany Announcements
Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer
5M ago
6K
ADAG
Adagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline
PremiumCompany Announcements
Adagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline
5M ago
6K
ADAG
Adagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 2028
PremiumCompany AnnouncementsAdagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 2028
5M ago
6K
ADAG
Adagene reports FY25 EPS (24c) vs (51c) last year
Premium
The Fly
Adagene reports FY25 EPS (24c) vs (51c) last year
5M ago
ADAG
Adagene (ADAG): De-Risked CTLA-4 Asset, Emerging Regulatory Clarity, and Strategic Partnerships Underpin Buy Rating
Premium
Ratings
Adagene (ADAG): De-Risked CTLA-4 Asset, Emerging Regulatory Clarity, and Strategic Partnerships Underpin Buy Rating
7M ago
ADAG
Adagene Outlines 2026 Clinical Milestones and Reports $74.5 Million Year-End Cash Runway
PremiumCompany Announcements
Adagene Outlines 2026 Clinical Milestones and Reports $74.5 Million Year-End Cash Runway
7M ago
6K
ADAG
Adagene provides objective for 2026
PremiumThe Fly
Adagene provides objective for 2026
7M ago
ADAG
Adagene announces FDA fast track designation for muzastotug
PremiumThe Fly
Adagene announces FDA fast track designation for muzastotug
8M ago
MRK
ADAG
Adagene initiated with a Buy at Guggenheim on muzastotug potential
PremiumThe Fly
Adagene initiated with a Buy at Guggenheim on muzastotug potential
9M ago
ADAG
Adagene initiated with a Buy at Guggenheim
PremiumThe FlyAdagene initiated with a Buy at Guggenheim
9M ago
ADAG
Adagene initiated with an Outperform at LifeSci Capital
Premium
The Fly
Adagene initiated with an Outperform at LifeSci Capital
9M ago
ADAG
Adagene and Third Arc Bio Forge Licensing Agreement for Cancer Therapy Development
Premium
Company Announcements
Adagene and Third Arc Bio Forge Licensing Agreement for Cancer Therapy Development
9M ago
6K
ADAG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >